Evidence map›Paper›PMID 41354647›Full record

ArticleNature communications2025

CD44 cross-linking promotes Plasmodium falciparum invasion.

Angel K Kongsomboonvech, Stephen W Scally, Yann Le Guen, Praveesh Valissery, Nichole D Salinas, Alan F Cowman, Niraj H Tolia, Elizabeth S Egan

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Angel K KongsomboonvechDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Stephen W ScallyThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.ORCID http://orcid.org/0000-0002-4264-7772
Yann Le GuenQuantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.ORCID http://orcid.org/0000-0001-6649-8364
Praveesh ValisseryDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.
Nichole D SalinasHost-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Alan F CowmanThe Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.ORCID http://orcid.org/0000-0001-5145-9004
Niraj H ToliaHost-Pathogen Interactions and Structural Vaccinology Section, Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2689-1337
Elizabeth S EganDepartment of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA. eegan@stanford.edu.ORCID http://orcid.org/0000-0002-2112-7700

Funding

Elucidating the functions of red blood cell factors in malaria parasite invasionR01HL166249 · NHLBI · STANFORD UNIVERSITY · PI Elizabeth S. Egan · 2023 to 2026
$3.0M
Training in Pediatric Nonmalignant Hematology and Stem Cell BiologyT32DK098132 · NIDDK · STANFORD UNIVERSITY · PI SAKAMOTO, KATHLEEN M · 2014 to 2022
$1.9M
NHLBI NIH HHS R01 HL166249NIDDK NIH HHS T32 DK098132U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL166249U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) T32DK098132-06
6 · The paper itself

Abstract

The ability of Plasmodium falciparum to invade and replicate asexually within human red blood cells (RBCs) is central to its pathogenicity. Invasion involves several host-parasite interactions, yet the required host factors remain underexplored, largely due to the intractability of mature RBCs. The transmembrane protein CD44 was identified as a host factor for P. falciparum invasion through a novel forward genetic screen. Here, we identify an anti-CD44 monoclonal antibody, BRIC 222, that significantly promotes P. falciparum invasion through CD44 cross-linking. CD44 cross-linking induced changes in the phosphorylation of RBC cytoskeletal proteins, consistent with a proposed role for CD44 as a co-receptor during invasion. CD44 cross-linking also altered the RBC membrane, increasing the accessibility of several surface proteins, including the essential invasion receptor Basigin. The parasite ligand Erythrocyte Binding Antigen-175 (EBA-175), which interacts with CD44, enhanced P. falciparum invasion and induced RBC membrane changes similarly to BRIC 222. Moreover, both BRIC 222 and EBA-175 increased binding of the PfRH5/PCRCR invasion complex to Basigin, an interaction known to be essential for invasion. We propose that CD44 cross-linking, potentially by EBA-175, serves to coordinate and enhance ligand-receptor interactions and promote signaling to the host cell cytoskeleton, making RBCs more permissive to P. falciparum invasion.

Indexed as

ErythrocytesHyaluronan ReceptorsMalaria, FalciparumPlasmodium falciparumAntibodies, MonoclonalAntigens, ProtozoanBasiginCarrier ProteinsCross-Linking ReagentsErythrocyte MembraneHost-Parasite InteractionsHumansPhosphorylationProtozoan ProteinsAntibodies, MonoclonalAntigens, ProtozoanBasiginBSG protein, humanCarrier ProteinsCD44 protein, humanCross-Linking Reagentserythrocyte-binding antigen 175, PlasmodiumHyaluronan ReceptorsProtozoan ProteinsRH5 protein, Plasmodium falciparum

Identifiers

PMID41354647
PMCPMC12789465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.